Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective (Q44305484)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective |
scientific article |
Statements
1 reference
Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective (English)
1 reference
Fredrik Borgström
1 reference
Niklas Zethraeus
1 reference
1 January 2003
1 reference
1 reference
100
1 reference
1-2
1 reference
36-40
1 reference
Identifiers
1 reference